Immunobiology of Tumor Necrosis Factor Receptor Superfamily
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Immunologic Research
- Vol. 26 (1-3), 323-336
- https://doi.org/10.1385/ir:26:1-3:323
Abstract
The proteins of the tumor necrosis factor (TNF) receptor superfamily are a group of cell-surface receptors critically involved in the maintenance of homeostasis of the immune system. By interacting with their corresponding ligands, these receptorseither induce cell death or promote cell survival of immune cells. The number of recognized members of the TNF receptor and ligand superfamily has expanded substantially in the last several years. More important, the biologic function of this group of proteins has been closely associated with the regulation of the immune respon se and the pathogene isis of autoimmune disease. Thus, the direct targeting of these receptorsby either inducing apoptosisorblocking survival of autoimmune T and B cells may be an im portant therapeutic strategy in the treatment of autoimmune disease. This review summarizes the recent progress in immunobiology of the TNF receptor superfamily and focuses on our studies of three critical family members—FasLaFas, TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL-Rs, and B lymphocytestimulator (BLyS)/BLyS-Rs—to demonstrate the therapeutic potential of targeting these receptors for the treatment of autoimmune disease.Keywords
This publication has 73 references indexed in Scilit:
- Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseasesArthritis & Rheumatism, 2001
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- CD40 AND CD154 IN CELL-MEDIATED IMMUNITYAnnual Review of Immunology, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- Apoptosis by Death FactorCell, 1997
- Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice.The Journal of Experimental Medicine, 1995
- The role of CD40 and its ligand (gp39) in peripheral and central tolerance and its contribution to autoimmune diseaseResearch in Immunology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr mice.The Journal of Experimental Medicine, 1992
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992